Time-lapse image analysis method that enables the rapidization of agar cultivation methods.
Limited to the first 20 people! Technical paper and novelty gift related to "Microbiome μ3D" will be presented!
This document is a technical paper on Microbio μ3D by Hiroyuki Ogawa (Microbio Co., Ltd.), published in the magazine "PHARM TECH JAPAN December 2016 issue special edition." The "time-lapse image analysis method" is an analytical method that fully automates the agar medium culture method, speeding up detection and counting. By transitioning from manual visual inspection to a fully automated rapid microbial detection device, we can expect a reduction in quality inspection time and labor. Currently, we are offering the original paper and a novelty item to the first 20 respondents! *Please note that what you can download is only a part of the paper. For more details, feel free to contact us.
Inquire About This Product
basic information
*You can download only a part of the paper. For more details, please feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
*You can download only a part of the paper. For more details, please feel free to contact us.*
catalog（1）
Download All Catalogs
Company information
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.
![Quality Control of Zero-Calorie Sweeteners Using Near-Infrared Analyzers [Technical Document]](https://image.mono.ipros.com/public/product/image/f4b/2001238736/IPROS96054929485259550160.jpeg?w=280&h=280)
